Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-snglycero-3-phosphocholine on B lymphocytes

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 2, 1998, Pages 231-237

  Mazer, Bruce D ^a   Toledano, Baruch ^a   Saririan, Mehrdad ^a   Bastien, Yolande ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Apoptosis; B lymphocytes; Immunoglobulin production; Lipid mediators; Platelet activating factor

Indexed keywords

1 PALMITOYL 2 ACETYLGLYCERO 3 PHOSPHOCHOLINE; IMMUNOGLOBULIN M; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0031723225     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70091-0     Document Type: Article

References (40)

1. Ishii S, Nagase T, Tashiro F, Ikuta K, Sato S, Waga I, et al. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J 1997;16:133-42.
2. Hilliquin P, Dulioust A, Gregoir C, Arnoux A, Menkes CJ. Production of PAF-acether by synovial fluid neutrophils in rheumatoid arthritis. Inflamm Res 1995;44:313-6.
3. McManus LM, Woodart DS, Deavers SI, Pinckard RN. PAF molecular heterogeneity: pathobiological implications. Lab Invest 1993;69:639-50.
4. Columbo M, Horowitz EM, Patella V, Kagey-Sobotka A, Chilton FH, Lichtenstein LM. A comparative study of the effects of 1-acyl-2-acetylsn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene release from human leukocytes. J Allergy Clin Immunol 1993;92:325-33.
5. Triggiani M, Schleimer RP, Warner JA, Chilton FH. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating-factor by human inflammatory cells. J Immunol 1991;147:660-6.
6. Triggiani M, Goldman D, Chilton FH. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochem Biophys Acta 1991;1084:41-7.
7. Shimizu, T, Izumi T, Shimizu T. Platelet-activating factor receptor: gene expression and signal transduction. Biochem Biophys Acta 1995;1259:317-33.
8. O'Flaherty JT, Tessner T, Greene D, Redman JR, Wykle RL. Comparison of 1-0-alkyl, 1-0-alk-1′-enyl-, and 1-0-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family. Biochem Biophys Acta 1994;210:209-16.
9. Tordai A, Franklin RA, Johnson C, Mazer BD, Clay KL, Gelfand EW. Autocrine stimulation of B lymphocytes by a platelet activating-factor agonist, 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine. J Immunol 1994;152:566-73.
10. Mazer B, Domenico J, Sawami H, Gelfand EW. Platelet activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B-lymphoblastoid cell lines. J Immunol 1991;146:1914-20.
11. Schulam PG, Kuruvilla A, Putcha G, Mangus L, Franklin-Johnson J, Shearer WT. Platelet activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B lymphocyte cell line. J Immunol 1991;146:1642-8.
12. Franklin RA, Mazer B, Sawami H, Mills GB, Terada N, Lucas JJ, et al. Platelet activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase activity in human B cells. J Immunol 1993;151:1802-10.
13. Kuruvilla A, Pielop C, Shearer WT. Platelet-activating factor induces the tyrosine phosphorylation and activation of phospholipase C-γ1, Lyn and Lyn kinases, and phosphotidylinositol 3′-kinase in a human B cell line. J Immunol 1994;153:5433-42.
14. Toledano BJ, BastienY, Noya F, Baruchel S, Mazer B. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol 1997;158:3705-15.
15. Mazer B, Clay K, Renz HE, Gelfand EW. Platelet-activating factor enhances Ig production in B-lymphoblastoid cell lines. J Immunol 1990;145:2602-7.
16. Kovar J, Franck F Serum free medium for hybridoma and parental myeloma cell cultivation. Methods Enzymol 1986;121:277-83.
17. Daryzynkiewcz Z. Assays of cell viability. Methods Cell Biol 1995;46:27-36.
18. Pinckard RN, Showell HJ, Castillo R, Lear C, Breslow R, McManus LM, et al. Differential responsiveness of human neutrophils to the autocrine actions of 1-0-alkyl-homologs and 1-acyl analogs of platelet-activating factor. J Immunol 1992;148:3528-35.
19. Sibley, DR, Lefkowich, RJ. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor coupled adenylate cyclase system as a model. Nature 1985;317:124-31.
20. Valone FH. Platelet-activating factor binding to specific cell membrane receptors. In: Snyder F, editor. Platelet-activating factor and related lipid mediators. New York: Plenum Press; 1987. p. 137-51.
21. Venable ME, Zimmerman GA, McIntyre TM, Prescott SM. Platelet-activating factor: a phospholipid autocoid with diverse actions. J Lipid Res 1993;34:691-702.
22. Koltai M, Hosford D, Braquet P. PAF-induced amplification of mediator release in septic shock: prevention or down-regulation by PAF antagonists. J Lipid Mediat 1993;6:183-98.
23. Barnes PJ. Platelet-activating factor and PAF antagonists in lung disease. Res Clin Forums 1991;13:61-74.
24. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes, tethering and signaling molecules. Immunol Today 1992;13:93-100.
25. Zhou W, Javors MA, Olson MS. Platelet-activating factor as an intracellular signal in neutrophil dependent platelet activation. J Immunol 1992;149:1763-9.
26. Bartheson R, Valone FH. Interaction of platelet-activating factor with interferon-γ in the stimulation of IL1 production by human monocytes. J Allergy Clin Immunol 1990;86:193-201.
27. Triggiani M, Fonteh AN, Chilton FH. Factors that influence the propor tions of platelet-activating factor and 1-acyl-2 acetyl-sn-glycero-3-phosphocholine synthesized by the mast cell. Biochem J 1992;286:497-503.
28. Clay KL, Johnson CA, Worthen GS. Biosynthesis of platelet-activating factor and 1-0-acyl analogues by endothelial cells. Biochem Biophys Acta 1991;1094:43-50.
29. 3H] acetyl-sn-glycero-3-phosphocholine, a structural analog of platelet-activating factor, by vascular endothelial cells. Biochem Biophys Res Commun 1991;176:1557-64.
30. Triggiani M, Hubbend WC, Chilton FH. Synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by an enriched preparation of the human lung mast cell. J Immunol 1990;144:4773-80.
31. Janeway CA, Travers P. Immunobiology. New York: Garland Publishing; 1996. p. 5:14-20.
32. Norvell A, Mandik L, Monroe JG. Engagement of the antigen receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol 1995;154:4404-12.
33. Rosskopf D, Hartung K, Hense J, Siffert W. Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients. Hypertension. 1995;6:432-5.
34. Denizot Y, Trimoreau F, Dupuis F, Verger C, Praloran V. PAF and hematopoiesis, III: presence and metabolism of platelet-activating factor in human bone marrow. Biochim Biophys Acta 1995;1265:55-60.
35. Nakamura M, Honda Z-I, Izumi T, Sakanaka C, Mutoh H, Minami M, et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991;266:20400-5.
36. Takano T, Honda Z, Sakanaka C, Izumi T, Kameyama K, Haga K, et al. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization. J Biol Chem 1994;269:22453-348.
37. Tuscano JM, Druey KM, Riva A, Pena J, Thompson CB, Kehrl JH. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood 1996;88:1359-64.
38. Bastien Y, Mazer B. Detection of mRNA for the platelet-activating factor receptor on human B lymphocytes by the polymerase chain reaction. Biochem Biophys Res Commun 1994;202:1373-9.
39. Deryckx S, de Waal Malefyt R, Gauchat JF, Vivier E, Thomas Y, de Vries JE. Immunoregulatory functions of Paf-acether, VIII: inhibition of IL4 induced human IgE synthesis in vitro. J Immunol 1992;148:1465-70.
40. Nguer CM, Treton D, Rola-Pleszczynski M, Mishal Z, Thomas Y, Galanaud P, et al. Regulation of platelet-activating factor receptor expression in human B cells and B cell lines. Lipids 1996;10:1051-8.